Compounded medications exist in a gray area
The surging demand has made GLP-1 therapies the fastest-growing sector in diabetes/obesity pharmacotherapy
The professional associations, societies, and current literature agree that an individualized approach should be taken to managing patients on GLP-1 medications
The Long Game The clinical evidence is unequivocal: When GLP-1 treatment stops, weight typically returns
Maximize Results The GLP-1 Support Patch Pack is crafted to help you achieve long-term success with your GLP-1 therapy by minimizing common side effects that can disrupt your progress
Zhang, Y., Li, X., Zou, D., Liu, W., Yang, J., Zhu, N., Huo, L., Wang, M., Hong, J., Wu, P., Ren, G., and Ning, G